Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611
This examiner grants 40% of resolved cases
Janet Joseph is a USPTO patent examiner in Tech Center 1600 and Art Unit 1611. The examiner has 55 resolved cases, which results in an allowance rate of 40.0%. This percentage provides a baseline for applicants evaluating their chances of success in this unit. The median days to allowance for these cases is 1474, indicating the duration of the prosecution process from filing to grant.
The data shows an interview lift of 51.3%. This lift suggests that applications involving an interview have a higher probability of allowance than those that do not. With 55 resolved cases, the examiner has a history of resolutions in Tech Center 1600. Practitioners can use the 1474-day median to manage client expectations regarding the timeline for a resolution.
In Art Unit 1611, the examiner's 40.0% allowance rate and 51.3% interview lift are metrics for strategy. The median pendency is a figure that describes the time required to reach an allowance. These data points from the resolved cases offer an overview of the examiner's performance. Applicants should consider the 51.3% lift when evaluating the benefits of verbal communication.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18708126 | COMPOSITION CONTAINING 3-HYDROXYANTHRANILIC ACID AND COMPOUNDS THAT ALTER IRON HOMEOSTASIS AND METHOD OF ITS USE | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 18084402 | COMPOSITIONS AND METHODS FOR REMOVING COLOR FROM HAIR | Final Rejection | L'Oreal |
| 17731759 | COMPOSITIONS SUITABLE AS SETTERS | Final Rejection | L'OREAL |
| 17731791 | COMPOSITIONS SUITABLE AS SETTERS | Final Rejection | L'OREAL |
| 18037316 | COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY | Non-Final OA | ARCUTIS BIOTHERAPEUTICS, INC. |
| 18708232 | SUSPENSION CONCENTRATE DISPERSANTS | Non-Final OA | Croda International PIc |
| 18021367 | DOSING CAPSULE MADE FROM CANNABIS-DERIVED RESIN AND METHODS OF MAKING THE SAME | Final Rejection | CAPHEADS LLC |
| 18250782 | MODIFIED RELEASE COMPOSITIONS COMPRISING MELATONIN | Final Rejection | NUTRIVENTIA PRIVATE LIMITED |
| 18132985 | TOPICAL STATIN FORMULATION FOR TREATMENT OF LICHEN SCLEROSUS AND PSORIASIS | Non-Final OA | TBT PHARMA, INC |
| 18013105 | PHARMACEUTICAL COMPOSITIONS FOR IMPROVED DELIVERY OF THERAPEUTIC LIPOPHILIC ACTIVES | Final Rejection | KARNAK TECHNOLOGIES, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy